Catalyst Pharmaceuticals Inc (CPRX)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 727,632 | 387,881 | 300,421 | 206,831 | 169,598 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $727,632K)
= 0.00
The debt-to-capital ratio of Catalyst Pharmaceuticals Inc has consistently remained at 0.00 over the five-year period from December 31, 2020, to December 31, 2024. This indicates that the company has been utilizing entirely equity financing rather than debt to fund its operations and investments. A debt-to-capital ratio of 0.00 suggests that the company has no financial leverage and is not relying on borrowed funds to support its capital structure. This low ratio can be seen as a positive sign, as it indicates lower financial risk and potential for financial stability. However, it is important to consider the overall financial strategy and capital allocation decisions of the company in conjunction with this ratio to get a holistic view of its financial health.
Peer comparison
Dec 31, 2024